New Perspective of Life Style Drugs

  • Mayank Dimri SBS University Balawala, Dehradun-248161 (Uttarakhand) India
  • Virbal Singh Rajwar SBS University Balawala, Dehradun-248161 (Uttarakhand), India
  • Luv Kush SBS University Balawala, Dehradun-248161 (Uttarakhand), India
  • Alok Maithani SBS University Balawala, Dehradun-248161 (Uttarakhand), India

Abstract

The life style drugs have opened a new therapeutical horizon in pharmaceutical scenario. They have booming market and became multi-million dollar international industry. The new categories of drugs – anti-obesity, anti-dementia and anti-phobial are included in them. Nootropics are novel life style products for males.


 

Keywords: Life style, New drug, Nootropics, Market, Boom.

Downloads

Download data is not yet available.

Author Biographies

Mayank Dimri, SBS University Balawala, Dehradun-248161 (Uttarakhand) India

SBS University Balawala, Dehradun-248161 (Uttarakhand) India

Virbal Singh Rajwar, SBS University Balawala, Dehradun-248161 (Uttarakhand), India

SBS University Balawala, Dehradun-248161 (Uttarakhand), India

Luv Kush, SBS University Balawala, Dehradun-248161 (Uttarakhand), India

SBS University Balawala, Dehradun-248161 (Uttarakhand), India

Alok Maithani, SBS University Balawala, Dehradun-248161 (Uttarakhand), India

SBS University Balawala, Dehradun-248161 (Uttarakhand), India

References

1. Burger’s Medicinal Chemistry and Drug Discovery book in ninth chapter of 6th edition volume 4, 2007, from pages 417-475.
2. Moldrup C. The use of terms ‘lifestyle medicines’ and ‘lifestyle drugs’. Pharm World Sci 2004; 26:193-6.
3. Rahman SZ, Gupta V, Dang A, Sukhlecha A. Lifestyle drugs in India: Are we ready for them? Australasian Med J 2010;1:186-9.
4. Economy Survey 2007-2008. India: Ministry of Finance, Govt. of India. Available from: http://www.indiabudget.nic.in/[ last updated on 2008 Apr 24] [last cited on 2010 Feb 9] .
5. Atkinsion T. Lifestyle drug market booming. Nature Med 2002; 8:909.[PubMed].
6. Flower RJ, Lifestyle drugs: Pharmacology and social agenda. Trends Pharmacol Sci 2004; 25:185-5.
7. Wick JZ, Lifestyle Drugs Straddle Medical and Social Domains. Pharmacy Times Available from: http:// www.pharmacytimes.com/issue/pharmacy/2006/2006-03/2006-03-5308. [last updated on 2006 Mae 1] [last cited on 2010 Feb 9].
8. Rhaman, et al: Impact of Lifestyle Drugs on Socity, Indian J Pharm Sci. 2010 Jul-Aug; 72(4): 409–413.J.Weber, The New Era of Lifestyle Drugs,available online at http://www.businessweeek.com/1998/19/b35777001.htm, accessed on December 28,2001
9. J.Weber, The New Era of Lifestyle Drugs,available online at http://www.businessweeek.com/1998/19/b35777001.htm, accessed on December 28,2001.
10. Gilbert D, Walley T, New B, Lifestyle medicine, Br Med J 2000; 321;1341-4.
11. Ornish D. Intensive Lifestyle changes and health reform. Lancet Oncol, 2009:10(7)638-639.
12. Young Sn. Lifestyle drugs, mood behavior and cognition. J Psychiatry Neurosci 2003; 28:87-9.
13. Rose SPR. ‘Smart Drugs’; Do they work? Are they ethical? Will they be legal? Nature Rev Neurosci 2002; 3:975-9. [PubMed].
14. Drugs for men 20 best- men’s health.
https://www.menshealth.com/uk/health/g26005278/best-drugs-for-men/
15. Marc Schneeberger et.al, Regulation of Energy Expenditure by Brainstem GABA Neurons, Cell (2019). DOI: 10.1016/jcell.2019.05.048.
16. www.ncbi.nlm.nih.gov.
17. https://www.nia.nih.gov/health/how-alzheimers-disease-treated#:~:text=These%20drugs%20may%20help%20reduce,and%20Aricept%C2%AE%20(donepezil).
18. https://anxieties.com/152/med-intro#:~:text=The%20selective%20serotonin%20reuptake%20inhibitors,)%20and%20escitalopram%20(Lexapro).
19. https://healthtalk.org/depression/newer-anti-depressant-medication#:~:text=The%20main%20types%20of%20antidepressant,)%20and%20sertraline%20(Lustral).
20. https://www.webmd.com/erectile-dysfunction/guide/future-treatments-ed. Future Treatments for Erectile Dysfunction.
Statistics
21 Views | 24 Downloads
How to Cite
Dimri, M., Rajwar, V., Kush, L., & Maithani, A. (2020). New Perspective of Life Style Drugs. Asian Journal of Pharmaceutical Research and Development, 8(5), 105-108. https://doi.org/https://doi.org/10.22270/ajprd.v8i5.774

Most read articles by the same author(s)